https://www.selleckchem.com/products/lxh254.html
Incident liver dysfunction (LD) after left ventricular assist device (LVAD) implantation has been previously associated with adverse outcomes, yet data on perioperative risk markers are sparse. We retrospectively reviewed consecutive patients undergoing continuous-flow LVAD implant between 2007 and 2017 at a single institution. Perioperative variables were evaluated by univariate modeling and adjusted for false discovery rate. Variables most significantly associated with incident INTERMACS-defined LD (INT-LD) were evaluated using logisti